Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Seroprevalence of Chagas infection in the donor population.

Zaniello BA, Kessler DA, Vine KM, Grima KM, Weisenberg SA.

PLoS Negl Trop Dis. 2012;6(7):e1771. doi: 10.1371/journal.pntd.0001771. Epub 2012 Jul 31.

2.

Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain).

Piron M, Vergés M, Muñoz J, Casamitjana N, Sanz S, Maymó RM, Hernández JM, Puig L, Portús M, Gascón J, Sauleda S.

Transfusion. 2008 Sep;48(9):1862-8. doi: 10.1111/j.1537-2995.2008.01789.x. Epub 2008 Jun 2.

PMID:
18522707
3.

Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi.

Custer B, Agapova M, Bruhn R, Cusick R, Kamel H, Tomasulo P, Biswas H, Tobler L, Lee TH, Caglioti S, Busch M.

Transfusion. 2012 Sep;52(9):1901-11. doi: 10.1111/j.1537-2995.2012.03569.x. Epub 2012 Feb 17.

PMID:
22339233
4.
5.
6.

Trypanosoma cruzi screening in Texas blood donors, 2008-2012.

Garcia MN, Woc-Colburn L, Rossmann SN, Townsend RL, Stramer SL, Bravo M, Kamel H, Beddard R, Townsend M, Oldham R, Bottazzi ME, Hotez PJ, Murray KO.

Epidemiol Infect. 2016 Apr;144(5):1010-3. doi: 10.1017/S0950268814002234. Epub 2014 Aug 29.

PMID:
25170765
7.

The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors.

Cantey PT, Stramer SL, Townsend RL, Kamel H, Ofafa K, Todd CW, Currier M, Hand S, Varnado W, Dotson E, Hall C, Jett PL, Montgomery SP.

Transfusion. 2012 Sep;52(9):1922-30. doi: 10.1111/j.1537-2995.2012.03581.x. Epub 2012 Mar 8.

PMID:
22404755
8.

Prevalence of Trypanosoma cruzi infection in blood donors in El Salvador between 2001 and 2011.

Sasagawa E, Guevara de Aguilar AV, Hernández de Ramírez MA, Romero Chévez JE, Nakagawa J, Cedillos RA, Misago C, Kita K.

J Infect Dev Ctries. 2014 Aug 13;8(8):1029-36. doi: 10.3855/jidc.4035.

9.

Chagas disease in Italy: breaking an epidemiological silence.

Angheben A, Anselmi M, Gobbi F, Marocco S, Monteiro G, Buonfrate D, Tais S, Talamo M, Zavarise G, Strohmeyer M, Bartalesi F, Mantella A, Di Tommaso M, Aiello Kh, Veneruso G, Graziani G, Ferrari M, Spreafico I, Bonifacio E, Gaiera G, Lanzafame M, Mascarello M, Cancrini G, Albajar-Vinas P, Bisoffi Z, Bartoloni A.

Euro Surveill. 2011 Sep 15;16(37). pii: 19969.

10.

[Epidemiologic knowledge and current situation of Chagas disease in the state of Jalisco, Mexico].

Lozano-Kasten F, Magallón-Gastélum E, Soto-Gutiérrez M, Kasten-Monges M, Bosseno MF, Brenière SF.

Salud Publica Mex. 2008 Nov-Dec;50(6):508-15. Spanish.

11.

[The prevalence of Trypanosoma cruzi infection in blood donors in the state of Jalisco, Mexico].

Trujillo Contreras F, Lozano Kasten F, Soto Gutiérrez MM, Hernández Gutiérrez R.

Rev Soc Bras Med Trop. 1993 Apr-Jun;26(2):89-92. Spanish.

PMID:
8128076
12.

[Trypanosoma cruzi infection in blood donor candidates].

Bonametti AM, Castelo Filho A, Ramos LR, Baldy JL, Matsuo T.

Rev Saude Publica. 1998 Dec;32(6):566-71. Portuguese.

PMID:
10349149
13.

Estimating the Burden of Chagas Disease in the United States.

Manne-Goehler J, Umeh CA, Montgomery SP, Wirtz VJ.

PLoS Negl Trop Dis. 2016 Nov 7;10(11):e0005033. doi: 10.1371/journal.pntd.0005033. eCollection 2016 Nov.

14.

Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors.

Leiby DA, Read EJ, Lenes BA, Yund AJ, Stumpf RJ, Kirchhoff LV, Dodd RY.

J Infect Dis. 1997 Oct;176(4):1047-52.

PMID:
9333165
15.

Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening.

El Ghouzzi MH, Boiret E, Wind F, Brochard C, Fittere S, Paris L, Mazier D, Sansonetti N, Bierling P.

Transfusion. 2010 Mar;50(3):575-83. doi: 10.1111/j.1537-2995.2009.02476.x. Epub 2009 Nov 9.

PMID:
19906038
16.

High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico.

Sánchez-Guillén MC, Barnabé C, Guégan JF, Tibayrenc M, Velásquez-Rojas M, Martínez-Munguía J, Salgado-Rosas H, Torres-Rasgado E, Rosas-Ramírez MI, Pérez-Fuentes R.

Mem Inst Oswaldo Cruz. 2002 Oct;97(7):947-52.

17.

Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico.

Galavíz-Silva L, Molina-Garza DP, González-Santos MA, Mercado-Hernández R, González-Galavíz JR, Rosales-Encina JL, Molina-Garza ZJ.

Am J Trop Med Hyg. 2009 Sep;81(3):404-6.

PMID:
19706904
18.

Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection.

Leiby DA, Herron RM Jr, Garratty G, Herwaldt BL.

J Infect Dis. 2008 Aug 15;198(4):609-13. doi: 10.1086/590159.

PMID:
18588482
19.
20.

[Heterogeneous distribution of the prevalence of anti-Trypanosoma cruzi antibodies among blood donors in the State of Puebla, Mexico].

Monteón VM, Reyes-López PA, Sosa-Palacio A, León-Tello G, Martínez-Murguía J, Sosa-Jurado F.

Salud Publica Mex. 2005 Mar-Apr;47(2):116-25. Spanish.

PMID:
15889637

Supplemental Content

Support Center